Gerhard H. Braus

Prof. Gerhard H. Braus

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
ÃSÖZlem Sarikaya-Bayram
ÖZlem Sarikaya-Bayram
JPJonathan M. Palmer
Jonathan M. Palmer
NKNancy Keller
Nancy Keller
GBGerhard H. Braus
Gerhard H. Braus
ÃBÖZgã¼R Bayram
ÖZgã¼R Bayram
Fungal secondary metabolism has become an important research topic with great biomedical and biotechnological value. In the postgenomic era, understanding the diversity and the molecular control of secondary metabolites are two challenging tasks addressed by the research community. Discovery of the LaeA methyltransferase 10 years ago opened up a new horizon on the control of secondary metabolite research when it was found that expression of many secondary metabolite gene clusters is controlled by LaeA. While the molecular function of LaeA remains an enigma, discovery of the velvet family proteins as interaction partners further extended the role of the LaeA beyond secondary metabolism. The heterotrimeric VelB-VeA-LaeA complex plays important roles in development, sporulation, secondary metabolism and pathogenicity. Recently, three other methyltransferases have been found to associate with the velvet complex, the LaeA-like methyltransferase F (LlmF) and the methyltransferase heterodimers VipC-VapB. Interaction of VeA with at least four methyltransferase proteins indicates a molecular hub function for VeA that questions: Is there a VeA supercomplex or is VeA part of a highly dynamic cellular control network with many different partners?

1 December 2005 in Nature
Verified
Journal Article
Open access
PDF file
JGJames E. Galagan
James E. Galagan
SCSarah E. Calvo
Sarah E. Calvo
Christina CuomoChristina Cuomo
Christina Cuomo
Li-Jun MaLi-Jun Ma
Li-Jun Ma
JWJennifer R. Wortman
Jennifer R. Wortman
BBBruce W. Birren
Bruce W. Birren
The aspergilli comprise a diverse group of filamentous fungi spanning over 200 million years of evolution. Here we report the genome sequence of the model organism Aspergillus nidulans, and a comparative study with Aspergillus fumigatus, a serious human pathogen, and Aspergillus oryzae, used in the production of sake, miso and soy sauce. Our analysis of genome structure provided a quantitative evaluation of forces driving long-term eukaryotic genome evolution. It also led to an experimentally validated model of mating-type locus evolution, suggesting the potential for sexual reproduction in A. fumigatus and A. oryzae. Our analysis of sequence conservation revealed over 5,000 non-coding regions actively conserved across all three species. Within these regions, we identified potential functional elements including a previously uncharacterized TPP riboswitch and motifs suggesting regulation in filamentous fungi by Puf family genes. We further obtained comparative and experimental evidence indicating widespread translational regulation by upstream open reading frames. These results enhance our understanding of these widely studied fungi as well as provide new insight into eukaryotic genome evolution and gene regulation.

13 June 2008 in Science
Verified
Journal Article
Closed access
PDF file
OBÖzGür Bayram
ÖzGür Bayram
Sven KrappmannSven Krappmann
Sven Krappmann
MNMin Ni
Min Ni
JBJin Woo Bok
Jin Woo Bok
KHKerstin Helmstaedt
Kerstin Helmstaedt
GBGerhard H. Braus
Gerhard H. Braus
Differentiation and secondary metabolism are correlated processes in fungi that respond to light. In Aspergillus nidulans , light inhibits sexual reproduction as well as secondary metabolism. We identified the heterotrimeric velvet complex VelB/VeA/LaeA connecting light-responding developmental regulation and control of secondary metabolism. VeA, which is primarily expressed in the dark, physically interacts with VelB, which is expressed during sexual development. VeA bridges VelB to the nuclear master regulator of secondary metabolism, LaeA. Deletion of either velB or veA results in defects in both sexual fruiting-body formation and the production of secondary metabolites.

1 January 2012 in FEMS Microbiology Reviews
Verified
Journal Article
Open access
PDF file
Özgür BayramÖzgür Bayram
Özgür Bayram
GBGerhard H. Braus
Gerhard H. Braus
The velvet family proteins have been the focus of fungal research in last decade. They are at the interface between development, sporulation and secondary metab

14 February 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
RVRonald de Vries
Ronald de Vries
RRRobert Riley
Robert Riley
AWAd Wiebenga
Ad Wiebenga
GOGuillermo Aguilar Osorio
Guillermo Aguilar Osorio
Sotiris AmillisSotiris Amillis
Sotiris Amillis
Igor GrigorievIgor Grigoriev
Igor Grigoriev
The fungal genus Aspergillus is of critical importance to humankind. Species include those with industrial applications, important pathogens of humans, animals and crops, a source of potent carcinogenic contaminants of food, and an important genetic model. The genome sequences of eight aspergilli have already been explored to investigate aspects of fungal biology, raising questions about evolution and specialization within this genus. We have generated genome sequences for ten novel, highly diverse Aspergillus species and compared these in detail to sister and more distant genera. Comparative studies of key aspects of fungal biology, including primary and secondary metabolism, stress response, biomass degradation, and signal transduction, revealed both conservation and diversity among the species. Observed genomic differences were validated with experimental studies. This revealed several highlights, such as the potential for sex in asexual species, organic acid production genes being a key feature of black aspergilli, alternative approaches for degrading plant biomass, and indications for the genetic basis of stress response. A genome-wide phylogenetic analysis demonstrated in detail the relationship of the newly genome sequenced species with other aspergilli. Many aspects of biological differences between fungal species cannot be explained by current knowledge obtained from genome sequences. The comparative genomics and experimental study, presented here, allows for the first time a genus-wide view of the biological diversity of the aspergilli and in many, but not all, cases linked genome differences to phenotype. Insights gained could be exploited for biotechnological and medical applications of fungi.

2 April 2020 in Fungal Biology and Biotechnology
Verified
Journal Article
Open access
PDF file
VMVera Meyer
Vera Meyer
EBEvelina Basenko
Evelina Basenko
JBJ. Philipp Benz
J. Philipp Benz
GBGerhard H. Braus
Gerhard H. Braus
MCMark X. Caddick
Mark X. Caddick
Han WöstenHan Wösten
Han Wösten
Fungi have the ability to transform organic materials into a rich and diverse set of useful products and provide distinct opportunities for tackling the urgent challenges before all humans. Fungal biotechnology can advance the transition from our petroleum-based economy into a bio-based circular economy and has the ability to sustainably produce resilient sources of food, feed, chemicals, fuels, textiles, and materials for construction, automotive and transportation industries, for furniture and beyond. Fungal biotechnology offers solutions for securing, stabilizing and enhancing the food supply for a growing human population, while simultaneously lowering greenhouse gas emissions. Fungal biotechnology has, thus, the potential to make a significant contribution to climate change mitigation and meeting the United Nation’s sustainable development goals through the rational improvement of new and established fungal cell factories. The White Paper presented here is the result of the 2nd Think Tank meeting held by the EUROFUNG consortium in Berlin in October 2019. This paper highlights discussions on current opportunities and research challenges in fungal biotechnology and aims to inform scientists, educators, the general public, industrial stakeholders and policymakers about the current fungal biotech revolution.